-
Diabetes and Obesity – WHO Updates Core Essential Medicines List, Charting a New Direction
Nov , 18 2025
Diabetes and obesity have emerged as two of the most urgent health challenges facing the world today. A staggering 800 million people were living with diabetes in 2022, with half remaining untreated. ...
read more
-
Orforglipron vs. Semaglutide vs. Tirzepatide: The Ultimate 2026 Weight Loss Drug Comparison
May , 21 2026
1. Introduction: The GLP-1 Evolution The weight loss pharmaceutical market has dramatically shifted with the 2026 FDA approval of Orforglipron (Foundayo). This new oral, non-peptide agonist challenges...
read more